Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase 1 1

Status

Completed 185Active not recruiting 30Terminated 24Recruiting 20Withdrawn 14Unknown 14Not yet recruiting 5

Sponsor Class

OTHER 629INDUSTRY 77OTHER_GOV 21NETWORK 5NIH 3UNKNOWN 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Genitourinary 8Sarcoma 5Other hematologic neoplasm 5Breast 5Gastrointestinal 4Thoracic 3Other solid neoplasm 3Lymphoid 3Dermatologic 3Tumor-Agnostic 1Plasma cell 1Gynecologic 1CNS 1

Conditions

Breast Neoplasms 2Triple Negative Breast Neoplasms 1Sarcoma, Alveolar Soft Part 1Musculoskeletal Pain 1Drug-Related Side Effects and Adverse Reactions 1Carcinoma, Renal Cell 1Breast Cancer Survivor 1Anatomic Stage IV Breast Cancer AJCC v8 1

Interventions

trastuzumab deruxtecan 1trastuzumab biosimilar HLX02 1taxane 1pertuzumab 1fludarabine 1Trastuzumab 1Taxoids 1Steroids 1Specimen Handling 1Radiotherapy 1Radiosurgery 1Radiation 1PF-05280014 1Ontruzant 1Ogivri 1Mastectomy, Simple 1Mastectomy, Segmental 1Magnetic Resonance Spectroscopy 1Hormones 1High-Energy Shock Waves 1Furosemide 1Duloxetine Hydrochloride 1Cyclophosphamide 1Cyclin-Dependent Kinase Inhibitor p18 1Cyclin-Dependent Kinase Inhibitor p16 1CT-P6 1Biopsy 1Ado-Trastuzumab Emtansine 12C4 antibody 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Not yet recruiting × NETWORK × Breast × Clear all
NCT07578116 2026-05-27

Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis

SWOG Cancer Research Network

Phase 3 Not yet recruiting
562 enrolled
Breast

Anatomic Stage IV Breast Cancer AJCC v8

NCT07297667 2026-05-12

GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours

Canadian Cancer Trials Group

Phase 1 Not yet recruiting
30 enrolled
BreastGenitourinarySarcoma

Carcinoma, Renal Cell, Sarcoma, Alveolar Soft Part, Triple Negative Breast Neoplasms

NCT07122492 2025-08-14

FoRtitude

Eastern Cooperative Oncology Group

Phase NA Not yet recruiting
800 enrolled
Breast

Breast Cancer Survivor

NCT06786585 2025-05-30

Extended Clinical Follow up and Biospecimen Collection for Patients Enrolled in TAILORx and RxPONDER: A Companion Protocol

Eastern Cooperative Oncology Group

Not yet recruiting
600 enrolled
Breast

Breast Neoplasms

NCT06407401 2024-11-05

Improvement of Quality of Life Through Supportive Treatments for Hormone Therapy - Related Symptoms in Patients With Early Breast Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Not yet recruiting
399 enrolled
Breast

Breast Neoplasms, Musculoskeletal Pain, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡